Vera Therapeutics Inc - Class A - fluxo de caixa trimestral (NASDAQ:VERA) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -39.18 M-54.41 M-54.8 M-61.91 M-69.99 M -241.1 M Cash from investing activities -221.38 M15.32 M28.54 M69.76 M80.66 M 194.29 M Cash from financing activities 325.95 M1.53 M20.29 M797 K286.28 M 308.9 M Free cash flow -39.83 M-54.59 M-55.01 M-62.04 M-70.1 M -241.73 M

Notícias

Vera Therapeutics nomeia Jane Wright-Mitchell como diretora jurídica

Wolfe Research eleva rating das ações da Vera Therapeutics com base na avaliação

Wolfe Research upgrades Vera Therapeutics stock rating on valuation

BofA Securities reafirma classificação de compra para Vera Therapeutics

Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vera Therapeutics nomeia Christopher Hite para o conselho de administração

Vera Therapeutics adds Christopher Hite to board of directors

3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg

Vera Therapeutics promove Matt Skelton a diretor comercial